Tag: UK Pharma

PhoreMost and C4X Discovery Partner in Neurodegeneration Focused Drug Discovery

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, today an...

Launching of New Psychiatric Drug Discovery Consortium

A new drug discovery consortium has been launched to help meet therapeutic needs for psychiatric symptoms affecting people with mental health conditions and dementia. The Psychiatry Consortium has ...

CMA Found 4 UK Companies Breaking Competition Law

The CMA has provisionally found that 4 pharmaceutical companies broke the law by agreeing not to compete in the supply of an anti-nausea drug in the UK. In a statement of objections issued, the Com...

Belarus Invites UK to Open Pharma Enterprise

Belarus invites the UK to open a pharmaceutical enterprise and an enterprise to make charging stations for electric cars in the China-Belarus industrial park Great Stone. The possibilities were discus...

Sanofi Plans Fly Supply of Flu Vaccine to UK after Brexit

Drugs company Sanofi has plans to fly supplies of flu vaccine into the UK if other transport routes are disrupted after the country leaves the EU. Hugo Fry, the managing director of its UK arm, tol...

GHO Capital Acquires Leader of Small Molecule API Development

GHO Capital, the European specialist investor in healthcare has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs. Headquartered in N...

UK Companies Broke Competition Law

The Competition and Markets Authority (CMA) has provisionally found that, from July 2011 to April 2015, the sole supplier of hydrocortisone tablets in the UK, Auden Mckenzie, and its rival, Waymade, e...

UK and Israel Bilateral Trade Agreement

Economy Minister Eli Cohen and British Secretary of State for International Trade Liam Fox put pen to paper on a bilateral trade continuity agreement in Tel Aviv on Monday, less than 40 days before th...

Supplier of Illicit Med Was Sentenced in UK

Today at Aylesbury Crown Court Keith Morgan of Milton Keynes was sentenced for illegally selling or supplying prescription-only medicine and unauthorised medicine. Morgan was sentenced to 2 years i...

Grey Wolf to Fund Development of Therapy Increasing Tumour Visibility

Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery ...

No-Deal Brexit Could Lead to Fake Med in UK

Drugmakers warned on Friday that if Britain leaves the European Union without a deal next month Britons could miss out on an EU-wide system to fight counterfeit drugs that will go live on Saturday aft...

AI Drugs Should Be Regulated Better

Products based on artificial intelligence should be regulated like drugs, and those that are deemed unsafe should be removed from the market, according to a new report. The report commissioned by N...

SID&GP about MoU and Relatioship with UK

On January 29, the UK and Russia have signed a memorandum of understanding enhancing cooperation in the field of regulation of medicines. Radio Sputnik discussed the development with Nikolay Tsatsy...

Russia to Inspect British Pharma Manufacturers

The Russian Ministry of Industry and Trade’s State Institute of Drugs and Good Practices plans to inspect five British pharmaceutical manufacturers for compliance with GMP standards in 2019. That’s ac...

Validair Expands Securing £150k in Funding

Validair Monitoring Solutions Limited has secured over £150k in funding from the Midlands Engine Investment Fund. The investment will support the company’s growth across the UK due to escalating deman...

Sphere Fluidics to Extend its Single Cell Analysis System

The Cambridge university spin-off will use the funding to accelerate growth in global operations and support sales of its Cyto-Mine Single Cell analysis system. Sphere Fluidics has closed a US$2 mi...